Literature DB >> 17331887

Molecular similarity analysis in virtual screening: foundations, limitations and novel approaches.

Hanna Eckert1, Jürgen Bajorath.   

Abstract

The success of ligand-based virtual-screening calculations is influenced highly by the nature of target-specific structure-activity relationships. This might pose severe constraints on the ability to recognize diverse structures with similar activity. Accordingly, the performance of similarity-based methods strongly depends on the class of compound that is studied, and approaches of different design and complexity often produce, overall, equally good (or bad) results. However, it is also found that there is often little overlap in the similarity relationships detected by different approaches, which rationalizes the need to develop alternative similarity methods. Among others, these include novel algorithms to navigate high-dimensional chemical spaces, train similarity calculations on specific compound classes, and detect remote similarity relationships.

Mesh:

Substances:

Year:  2007        PMID: 17331887     DOI: 10.1016/j.drudis.2007.01.011

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  82 in total

1.  Novel coumarin-based tyrosinase inhibitors discovered by OECD principles-validated QSAR approach from an enlarged, balanced database.

Authors:  Huong Le-Thi-Thu; Gerardo M Casañola-Martín; Yovani Marrero-Ponce; Antonio Rescigno; Luciano Saso; Virinder S Parmar; Francisco Torrens; Concepción Abad
Journal:  Mol Divers       Date:  2010-09-03       Impact factor: 2.943

2.  ScafBank: a public comprehensive Scaffold database to support molecular hopping.

Authors:  Bi-Bo Yan; Meng-Zhu Xue; Bing Xiong; Ke Liu; Ding-Yu Hu; Jing-Kang Shen
Journal:  Acta Pharmacol Sin       Date:  2009-01-19       Impact factor: 6.150

3.  Analysis and use of fragment-occurrence data in similarity-based virtual screening.

Authors:  Shereena M Arif; John D Holliday; Peter Willett
Journal:  J Comput Aided Mol Des       Date:  2009-06-18       Impact factor: 3.686

Review 4.  Exploiting drug-disease relationships for computational drug repositioning.

Authors:  Joel T Dudley; Tarangini Deshpande; Atul J Butte
Journal:  Brief Bioinform       Date:  2011-06-20       Impact factor: 11.622

Review 5.  Application of NMR and molecular docking in structure-based drug discovery.

Authors:  Jaime L Stark; Robert Powers
Journal:  Top Curr Chem       Date:  2012

6.  LIGSIFT: an open-source tool for ligand structural alignment and virtual screening.

Authors:  Ambrish Roy; Jeffrey Skolnick
Journal:  Bioinformatics       Date:  2014-10-21       Impact factor: 6.937

7.  Evaluation of different virtual screening strategies on the basis of compound sets with characteristic core distributions and dissimilarity relationships.

Authors:  Tomoyuki Miyao; Swarit Jasial; Jürgen Bajorath; Kimito Funatsu
Journal:  J Comput Aided Mol Des       Date:  2019-08-21       Impact factor: 3.686

Review 8.  Structure and dynamics of molecular networks: a novel paradigm of drug discovery: a comprehensive review.

Authors:  Peter Csermely; Tamás Korcsmáros; Huba J M Kiss; Gábor London; Ruth Nussinov
Journal:  Pharmacol Ther       Date:  2013-02-04       Impact factor: 12.310

9.  Shallow Representation Learning via Kernel PCA Improves QSAR Modelability.

Authors:  Stefano E Rensi; Russ B Altman
Journal:  J Chem Inf Model       Date:  2017-08-07       Impact factor: 4.956

10.  Application of 3D Zernike descriptors to shape-based ligand similarity searching.

Authors:  Vishwesh Venkatraman; Padmasini Ramji Chakravarthy; Daisuke Kihara
Journal:  J Cheminform       Date:  2009-12-17       Impact factor: 5.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.